বাংলায় দেখুন

Sparonex

Tablet

🧬 Sparfloxacin 🏢 Drug International Ltd.

Generic Name Sparfloxacin

Manufacturer Drug International Ltd.

Unit Price Unit Price: ৳ 18.00 (2 x 10: ৳ 360.00) Strip Price: ৳ 180.00

🔹 Indications নির্দেশনা

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pharmacology ফার্মাকোলজি

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Dosage & Administration

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Interaction মিথস্ক্রিয়া

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Contraindications

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Side Effects

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pregnancy & Lactation

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Precautions & Warnings সতর্কতা

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparonex is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔍 People also search for

Sparonex Sparonex Tablet used for Sparonex side effects Sparonex price Sparonex dose Sparonex Tablet uses Is Sparonex safe Sparonex dosage Sparonex alternative Sparonex Bangladesh Sparfloxacin Sparfloxacin price Bangladesh Tablet price Bangladesh Drug International Ltd. medicine bd

💡 Frequently Asked Questions

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

Sparonex is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

User Reviews

⭐

No reviews yet!

Be the first to share your experience.

Write a Review